Global Specialty Generics Market Research Report 2023

The global Specialty Generics market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North American market for Specialty Generics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Specialty Generics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global market for Specialty Generics in Retail Pharmacies is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global companies of Specialty Generics include Teva Pharmaceuticals Industries, Akorn, Inc., Mylan N.V., Mallinckrodt, Sandoz International GmbH, Pfizer, Inc., Sun Pharmaceutical Industries Ltd., Valeant Pharmaceuticals and Apotex Corp., etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Specialty Generics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Specialty Generics.

The Specialty Generics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Specialty Generics market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Specialty Generics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Specialty Generics Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Injectables

1.2.3 Oral

1.2.4 Others

1.3 Market by Application

1.3.1 Global Specialty Generics Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Retail Pharmacies

1.3.3 Specialty Pharmacies

1.3.4 Hospital Pharmacies

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Specialty Generics Market Perspective (2018-2029)

2.2 Specialty Generics Growth Trends by Region

2.2.1 Global Specialty Generics Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Specialty Generics Historic Market Size by Region (2018-2023)

2.2.3 Specialty Generics Forecasted Market Size by Region (2024-2029)

2.3 Specialty Generics Market Dynamics

2.3.1 Specialty Generics Industry Trends

2.3.2 Specialty Generics Market Drivers

2.3.3 Specialty Generics Market Challenges

2.3.4 Specialty Generics Market Restraints

3.1 Global Top Specialty Generics Players by Revenue

3.1.1 Global Top Specialty Generics Players by Revenue (2018-2023)

3.1.2 Global Specialty Generics Revenue Market Share by Players (2018-2023)

3.2 Global Specialty Generics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Specialty Generics Revenue

3.4 Global Specialty Generics Market Concentration Ratio

3.4.1 Global Specialty Generics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Specialty Generics Revenue in 2022

3.5 Specialty Generics Key Players Head office and Area Served

3.6 Key Players Specialty Generics Product Solution and Service

3.7 Date of Enter into Specialty Generics Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Specialty Generics Historic Market Size by Type (2018-2023)

4.2 Global Specialty Generics Forecasted Market Size by Type (2024-2029)

5.1 Global Specialty Generics Historic Market Size by Application (2018-2023)

5.2 Global Specialty Generics Forecasted Market Size by Application (2024-2029)

6.1 North America Specialty Generics Market Size (2018-2029)

6.2 North America Specialty Generics Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Specialty Generics Market Size by Country (2018-2023)

6.4 North America Specialty Generics Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Specialty Generics Market Size (2018-2029)

7.2 Europe Specialty Generics Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Specialty Generics Market Size by Country (2018-2023)

7.4 Europe Specialty Generics Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Specialty Generics Market Size (2018-2029)

8.2 Asia-Pacific Specialty Generics Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Specialty Generics Market Size by Region (2018-2023)

8.4 Asia-Pacific Specialty Generics Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Specialty Generics Market Size (2018-2029)

9.2 Latin America Specialty Generics Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Specialty Generics Market Size by Country (2018-2023)

9.4 Latin America Specialty Generics Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Specialty Generics Market Size (2018-2029)

10.2 Middle East & Africa Specialty Generics Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Specialty Generics Market Size by Country (2018-2023)

10.4 Middle East & Africa Specialty Generics Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Teva Pharmaceuticals Industries

11.1.1 Teva Pharmaceuticals Industries Company Detail

11.1.2 Teva Pharmaceuticals Industries Business Overview

11.1.3 Teva Pharmaceuticals Industries Specialty Generics Introduction

11.1.4 Teva Pharmaceuticals Industries Revenue in Specialty Generics Business (2018-2023)

11.1.5 Teva Pharmaceuticals Industries Recent Development

11.2 Akorn, Inc.

11.2.1 Akorn, Inc. Company Detail

11.2.2 Akorn, Inc. Business Overview

11.2.3 Akorn, Inc. Specialty Generics Introduction

11.2.4 Akorn, Inc. Revenue in Specialty Generics Business (2018-2023)

11.2.5 Akorn, Inc. Recent Development

11.3 Mylan N.V.

11.3.1 Mylan N.V. Company Detail

11.3.2 Mylan N.V. Business Overview

11.3.3 Mylan N.V. Specialty Generics Introduction

11.3.4 Mylan N.V. Revenue in Specialty Generics Business (2018-2023)

11.3.5 Mylan N.V. Recent Development

11.4 Mallinckrodt

11.4.1 Mallinckrodt Company Detail

11.4.2 Mallinckrodt Business Overview

11.4.3 Mallinckrodt Specialty Generics Introduction

11.4.4 Mallinckrodt Revenue in Specialty Generics Business (2018-2023)

11.4.5 Mallinckrodt Recent Development

11.5 Sandoz International GmbH

11.5.1 Sandoz International GmbH Company Detail

11.5.2 Sandoz International GmbH Business Overview

11.5.3 Sandoz International GmbH Specialty Generics Introduction

11.5.4 Sandoz International GmbH Revenue in Specialty Generics Business (2018-2023)

11.5.5 Sandoz International GmbH Recent Development

11.6 Pfizer, Inc.

11.6.1 Pfizer, Inc. Company Detail

11.6.2 Pfizer, Inc. Business Overview

11.6.3 Pfizer, Inc. Specialty Generics Introduction

11.6.4 Pfizer, Inc. Revenue in Specialty Generics Business (2018-2023)

11.6.5 Pfizer, Inc. Recent Development

11.7 Sun Pharmaceutical Industries Ltd.

11.7.1 Sun Pharmaceutical Industries Ltd. Company Detail

11.7.2 Sun Pharmaceutical Industries Ltd. Business Overview

11.7.3 Sun Pharmaceutical Industries Ltd. Specialty Generics Introduction

11.7.4 Sun Pharmaceutical Industries Ltd. Revenue in Specialty Generics Business (2018-2023)

11.7.5 Sun Pharmaceutical Industries Ltd. Recent Development

11.8 Valeant Pharmaceuticals

11.8.1 Valeant Pharmaceuticals Company Detail

11.8.2 Valeant Pharmaceuticals Business Overview

11.8.3 Valeant Pharmaceuticals Specialty Generics Introduction

11.8.4 Valeant Pharmaceuticals Revenue in Specialty Generics Business (2018-2023)

11.8.5 Valeant Pharmaceuticals Recent Development

11.9 Apotex Corp.

11.9.1 Apotex Corp. Company Detail

11.9.2 Apotex Corp. Business Overview

11.9.3 Apotex Corp. Specialty Generics Introduction

11.9.4 Apotex Corp. Revenue in Specialty Generics Business (2018-2023)

11.9.5 Apotex Corp. Recent Development

11.10 Endo International plc.

11.10.1 Endo International plc. Company Detail

11.10.2 Endo International plc. Business Overview

11.10.3 Endo International plc. Specialty Generics Introduction

11.10.4 Endo International plc. Revenue in Specialty Generics Business (2018-2023)

11.10.5 Endo International plc. Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Specialty Generics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Injectables

    Table 3. Key Players of Oral

    Table 4. Key Players of Others

    Table 5. Global Specialty Generics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 6. Global Specialty Generics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 7. Global Specialty Generics Market Size by Region (2018-2023) & (US$ Million)

    Table 8. Global Specialty Generics Market Share by Region (2018-2023)

    Table 9. Global Specialty Generics Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 10. Global Specialty Generics Market Share by Region (2024-2029)

    Table 11. Specialty Generics Market Trends

    Table 12. Specialty Generics Market Drivers

    Table 13. Specialty Generics Market Challenges

    Table 14. Specialty Generics Market Restraints

    Table 15. Global Specialty Generics Revenue by Players (2018-2023) & (US$ Million)

    Table 16. Global Specialty Generics Market Share by Players (2018-2023)

    Table 17. Global Top Specialty Generics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Specialty Generics as of 2022)

    Table 18. Ranking of Global Top Specialty Generics Companies by Revenue (US$ Million) in 2022

    Table 19. Global 5 Largest Players Market Share by Specialty Generics Revenue (CR5 and HHI) & (2018-2023)

    Table 20. Key Players Headquarters and Area Served

    Table 21. Key Players Specialty Generics Product Solution and Service

    Table 22. Date of Enter into Specialty Generics Market

    Table 23. Mergers & Acquisitions, Expansion Plans

    Table 24. Global Specialty Generics Market Size by Type (2018-2023) & (US$ Million)

    Table 25. Global Specialty Generics Revenue Market Share by Type (2018-2023)

    Table 26. Global Specialty Generics Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 27. Global Specialty Generics Revenue Market Share by Type (2024-2029)

    Table 28. Global Specialty Generics Market Size by Application (2018-2023) & (US$ Million)

    Table 29. Global Specialty Generics Revenue Market Share by Application (2018-2023)

    Table 30. Global Specialty Generics Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 31. Global Specialty Generics Revenue Market Share by Application (2024-2029)

    Table 32. North America Specialty Generics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 33. North America Specialty Generics Market Size by Country (2018-2023) & (US$ Million)

    Table 34. North America Specialty Generics Market Size by Country (2024-2029) & (US$ Million)

    Table 35. Europe Specialty Generics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 36. Europe Specialty Generics Market Size by Country (2018-2023) & (US$ Million)

    Table 37. Europe Specialty Generics Market Size by Country (2024-2029) & (US$ Million)

    Table 38. Asia-Pacific Specialty Generics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 39. Asia-Pacific Specialty Generics Market Size by Region (2018-2023) & (US$ Million)

    Table 40. Asia-Pacific Specialty Generics Market Size by Region (2024-2029) & (US$ Million)

    Table 41. Latin America Specialty Generics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 42. Latin America Specialty Generics Market Size by Country (2018-2023) & (US$ Million)

    Table 43. Latin America Specialty Generics Market Size by Country (2024-2029) & (US$ Million)

    Table 44. Middle East & Africa Specialty Generics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 45. Middle East & Africa Specialty Generics Market Size by Country (2018-2023) & (US$ Million)

    Table 46. Middle East & Africa Specialty Generics Market Size by Country (2024-2029) & (US$ Million)

    Table 47. Teva Pharmaceuticals Industries Company Detail

    Table 48. Teva Pharmaceuticals Industries Business Overview

    Table 49. Teva Pharmaceuticals Industries Specialty Generics Product

    Table 50. Teva Pharmaceuticals Industries Revenue in Specialty Generics Business (2018-2023) & (US$ Million)

    Table 51. Teva Pharmaceuticals Industries Recent Development

    Table 52. Akorn, Inc. Company Detail

    Table 53. Akorn, Inc. Business Overview

    Table 54. Akorn, Inc. Specialty Generics Product

    Table 55. Akorn, Inc. Revenue in Specialty Generics Business (2018-2023) & (US$ Million)

    Table 56. Akorn, Inc. Recent Development

    Table 57. Mylan N.V. Company Detail

    Table 58. Mylan N.V. Business Overview

    Table 59. Mylan N.V. Specialty Generics Product

    Table 60. Mylan N.V. Revenue in Specialty Generics Business (2018-2023) & (US$ Million)

    Table 61. Mylan N.V. Recent Development

    Table 62. Mallinckrodt Company Detail

    Table 63. Mallinckrodt Business Overview

    Table 64. Mallinckrodt Specialty Generics Product

    Table 65. Mallinckrodt Revenue in Specialty Generics Business (2018-2023) & (US$ Million)

    Table 66. Mallinckrodt Recent Development

    Table 67. Sandoz International GmbH Company Detail

    Table 68. Sandoz International GmbH Business Overview

    Table 69. Sandoz International GmbH Specialty Generics Product

    Table 70. Sandoz International GmbH Revenue in Specialty Generics Business (2018-2023) & (US$ Million)

    Table 71. Sandoz International GmbH Recent Development

    Table 72. Pfizer, Inc. Company Detail

    Table 73. Pfizer, Inc. Business Overview

    Table 74. Pfizer, Inc. Specialty Generics Product

    Table 75. Pfizer, Inc. Revenue in Specialty Generics Business (2018-2023) & (US$ Million)

    Table 76. Pfizer, Inc. Recent Development

    Table 77. Sun Pharmaceutical Industries Ltd. Company Detail

    Table 78. Sun Pharmaceutical Industries Ltd. Business Overview

    Table 79. Sun Pharmaceutical Industries Ltd. Specialty Generics Product

    Table 80. Sun Pharmaceutical Industries Ltd. Revenue in Specialty Generics Business (2018-2023) & (US$ Million)

    Table 81. Sun Pharmaceutical Industries Ltd. Recent Development

    Table 82. Valeant Pharmaceuticals Company Detail

    Table 83. Valeant Pharmaceuticals Business Overview

    Table 84. Valeant Pharmaceuticals Specialty Generics Product

    Table 85. Valeant Pharmaceuticals Revenue in Specialty Generics Business (2018-2023) & (US$ Million)

    Table 86. Valeant Pharmaceuticals Recent Development

    Table 87. Apotex Corp. Company Detail

    Table 88. Apotex Corp. Business Overview

    Table 89. Apotex Corp. Specialty Generics Product

    Table 90. Apotex Corp. Revenue in Specialty Generics Business (2018-2023) & (US$ Million)

    Table 91. Apotex Corp. Recent Development

    Table 92. Endo International plc. Company Detail

    Table 93. Endo International plc. Business Overview

    Table 94. Endo International plc. Specialty Generics Product

    Table 95. Endo International plc. Revenue in Specialty Generics Business (2018-2023) & (US$ Million)

    Table 96. Endo International plc. Recent Development

    Table 97. Research Programs/Design for This Report

    Table 98. Key Data Information from Secondary Sources

    Table 99. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Specialty Generics Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Specialty Generics Market Share by Type: 2022 VS 2029

    Figure 3. Injectables Features

    Figure 4. Oral Features

    Figure 5. Others Features

    Figure 6. Global Specialty Generics Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 7. Global Specialty Generics Market Share by Application: 2022 VS 2029

    Figure 8. Retail Pharmacies Case Studies

    Figure 9. Specialty Pharmacies Case Studies

    Figure 10. Hospital Pharmacies Case Studies

    Figure 11. Specialty Generics Report Years Considered

    Figure 12. Global Specialty Generics Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 13. Global Specialty Generics Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 14. Global Specialty Generics Market Share by Region: 2022 VS 2029

    Figure 15. Global Specialty Generics Market Share by Players in 2022

    Figure 16. Global Top Specialty Generics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Specialty Generics as of 2022)

    Figure 17. The Top 10 and 5 Players Market Share by Specialty Generics Revenue in 2022

    Figure 18. North America Specialty Generics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 19. North America Specialty Generics Market Share by Country (2018-2029)

    Figure 20. United States Specialty Generics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 21. Canada Specialty Generics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 22. Europe Specialty Generics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 23. Europe Specialty Generics Market Share by Country (2018-2029)

    Figure 24. Germany Specialty Generics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 25. France Specialty Generics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. U.K. Specialty Generics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. Italy Specialty Generics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. Russia Specialty Generics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Nordic Countries Specialty Generics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Asia-Pacific Specialty Generics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Asia-Pacific Specialty Generics Market Share by Region (2018-2029)

    Figure 32. China Specialty Generics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. Japan Specialty Generics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. South Korea Specialty Generics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. Southeast Asia Specialty Generics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. India Specialty Generics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. Australia Specialty Generics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. Latin America Specialty Generics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. Latin America Specialty Generics Market Share by Country (2018-2029)

    Figure 40. Mexico Specialty Generics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. Brazil Specialty Generics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Middle East & Africa Specialty Generics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Middle East & Africa Specialty Generics Market Share by Country (2018-2029)

    Figure 44. Turkey Specialty Generics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. Saudi Arabia Specialty Generics Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 46. Teva Pharmaceuticals Industries Revenue Growth Rate in Specialty Generics Business (2018-2023)

    Figure 47. Akorn, Inc. Revenue Growth Rate in Specialty Generics Business (2018-2023)

    Figure 48. Mylan N.V. Revenue Growth Rate in Specialty Generics Business (2018-2023)

    Figure 49. Mallinckrodt Revenue Growth Rate in Specialty Generics Business (2018-2023)

    Figure 50. Sandoz International GmbH Revenue Growth Rate in Specialty Generics Business (2018-2023)

    Figure 51. Pfizer, Inc. Revenue Growth Rate in Specialty Generics Business (2018-2023)

    Figure 52. Sun Pharmaceutical Industries Ltd. Revenue Growth Rate in Specialty Generics Business (2018-2023)

    Figure 53. Valeant Pharmaceuticals Revenue Growth Rate in Specialty Generics Business (2018-2023)

    Figure 54. Apotex Corp. Revenue Growth Rate in Specialty Generics Business (2018-2023)

    Figure 55. Endo International plc. Revenue Growth Rate in Specialty Generics Business (2018-2023)

    Figure 56. Bottom-up and Top-down Approaches for This Report

    Figure 57. Data Triangulation

    Figure 58. Key Executives Interviewed